LOS ANGELES—MJIC Inc. completed its quarterly rebalancing of the...

LOS ANGELES—MJIC Inc. completed its quarterly rebalancing of the Marijuana Index, adding seven new cannabis companies to theCanadian Marijuana Index.

The U.S. Marijuana Index and Canadian Marijuana Index track the top performing public cannabis companies operating in the United States and Canada, respectively. These indeces are combined to create the North American Marijuana Index. Each index is equal-weighted and rebalanced quarterly.

The North American Marijuana Index now has 39 constituents, with the U.S. Marijuana Index and the Canadian Marijuana Index containing 15 constituents and 24 constituents, respectively.

The minimum trading requirements for companies to join the indices increased for the quarter. Companies must have achieved a weighted average minimum market capitalization of $40 million USD, daily trading volume of $400,000 USD, and share price of $0.10 USD. Companies with more than $5 million USD of revenue over the prior year are exempt from the above trading requirements.

No new companies were added to the United States Marijuana Index.

Companies added to the Canadian Marijuana Index include:

• Cannabix Technologies, Inc. (CSE:BLO) (OTC:BLOZF) is developing tools for law enforcement and the workplace to detect THC in breath.
• Harvest One Cannabis Inc. (TSX-V:HVST) (OTC:HRVOF) is a Licensed Producer headquartered in Vancouver, British Columbia.
• InMed Pharmaceuticals Inc. (CSE:IN) (OTC:IMLFF) is a drug discovery and development company focused on the use of cannabinoids.
• Invictus MD Strategies Corp. (TSX-V:IMH) (OTC:IVITF) manages and operates several Licensed Producers across Canada.
• MYM Nutraceuticals Inc. (CSE:MYM) (OTC:MYMMF) is focused on launching cannabis production facilities in Canada and Australia.
• THC Biomed Intl Ltd. (CSE:THC) (OTC:THCBF) is a Licensed Producer headquartered in Kelowna, British Columbia.
• WeedMD, Inc. (TSX-V:WMD) (OTC:WDDMF) is a Licensed Producer headquartered in Aylmer, Ontario.

“The fourth quarter of 2017 saw significant gains in both the U.S. and Canadian cannabis public markets, as the North American Index increased 4% in October, 41% in November, and 61% in December. The quarter was highlighted by Constellation Brands’ $245 million CAD investment in Canopy Growth Corporation (TSX:WEED) at the end of October, and investors’ anticipation of the beginning of recreational cannabis in California starting January 2018,” said Dan Nicholls, Vice President. “Overall, the Canadian Marijuana Index increased 188% in the fourth quarter, reaching its all-time high, and the U.S. Marijuana Index increased 85%.”